Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Wanbury Limited ( (IN:WANBURY) ) has shared an update.
Wanbury Limited has announced the approval of several significant financial and operational measures. These include the issuance of Non-Convertible Debentures worth up to Rs. 200 Crore, with Rs. 175 Crore being raised from the Emerging India Credit Opportunities Fund II through private placement. Additionally, 200,000 stock options were granted to company employees under the WANBURY ESOP 2016 plan, reflecting the company’s commitment to enhancing employee engagement and retention. These developments are expected to strengthen Wanbury’s financial position and support its strategic objectives.
More about Wanbury Limited
Wanbury Limited operates in the pharmaceutical industry, focusing on the development, manufacture, and sale of pharmaceutical products. The company’s market focus is on providing innovative healthcare solutions across various therapeutic segments.
YTD Price Performance: -27.70%
Average Trading Volume: 22,819
Current Market Cap: 7.55B INR
Find detailed analytics on WANBURY stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue